Which closed-end funds own Adaptive Biotechnologies Corp?
2 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $19.7M. Security type: common equity. Country: United States. CUSIP 00650F109 · ISIN US00650F1093 · ticker ADPT.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 1.07% | $7.4M | 344,653 sh | $690M | 3.5% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.90% | $12.3M | 574,345 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
2 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Adaptive Biotechnologies | debt security | 7 |
Issuer-level search for “ADPT” → · Compare two funds’ portfolios →